Wednesday, December 09, 2020 6:11:35 PM
https://www.globenewswire.com/news-release/2020/12/09/2142316/0/en/Y-mAbs-Announces-Update-on-DANYELZA-naxitamab-gqgk-at-ESMO.html
Recent YMAB News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 01:51:28 PM
- Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan • GlobeNewswire Inc. • 11/04/2024 12:35:00 PM
- Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 10/25/2024 11:05:00 AM
- Y-mAbs to Participate in Upcoming Investor Conferences in October • GlobeNewswire Inc. • 10/01/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:16:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 08:15:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 12:05:37 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 09:24:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:19:43 PM
- Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer Research • GlobeNewswire Inc. • 09/06/2024 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 09:00:28 PM
- Y-mAbs to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 09/03/2024 12:32:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 08:15:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2024 09:12:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:05:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2024 08:12:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 11:06:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 10:50:43 AM
- Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments • GlobeNewswire Inc. • 08/12/2024 10:30:00 AM
- Y-mAbs to Participate in Upcoming Investor Conferences in August • GlobeNewswire Inc. • 08/07/2024 11:05:00 AM
- Y-mAbs Announces Second Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 08/05/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 08:15:27 PM
- Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer • GlobeNewswire Inc. • 07/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 01:02:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 01:01:37 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM